Feedback / Questions
ANPD001 - Aspen Neurosci
https://www.prnewswire.com/news-releases/aspen-neuroscience-announces-6-month-aspiro-phase-12a-clinical-trial-results-of-personalized-cell-therapy-for-parkinsons-disease-302448009.html
May 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next